|
1
|
Bhandaru M, Ardekani GS, Zhang G, Martinka
M, McElwee KJ, Li G and Rotte A: A combination of p300 and Braf
expression in the diagnosis and prognosis of melanoma. BMC Cancer.
14:3982014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berrocal A, Cabañas L, Espinosa E,
Fernández-de-Misa R, Martín-Algarra S, Martínez-Cedres JC,
Ríos-Buceta L and Rodríguez-Peralto JL: Melanoma: Diagnosis,
staging, and treatment. consensus group recommendations. Adv Ther.
31:945–960. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mishra H, Mishra PK, Ekielski A, Jaggi M,
Iqbal Z and Talegaonkar S: Melanoma treatment: From conventional to
nanotechnology. J Cancer Res Clin Oncol. 144:2283–2302. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang M and Zhang N: Clinical and
prognostic factors in 98 patients with malignant melanoma in China.
J Int Med Res. 45:1369–1377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wan X, Zhu Y, Zhang L and Hou W: Gefitinib
inhibits malignant melanoma cells through the VEGF/AKT signaling
pathway. Mol Med Rep. 17:7351–7355. 2018.PubMed/NCBI
|
|
6
|
Kang X, Zeng Y, Liang J, Li J, Ren D, Chai
L, Sun Z, Yu S, Wu X, Han W and Wang W: Aberrations and clinical
significance of BRAF in malignant melanoma. Medicine. 97:e95092018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
You H, Yang J, Liu Q, Tang L, Bu Q, Pan Z
and Lyu J: The impact of the lymph node density on overall survival
in patients with Wilms' tumor: A SEER analysis. Cancer Manag Res.
10:671–677. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Duggan MA, Anderson WF, Altekruse S,
Penberthy L and Sherman ME: The surveillance, epidemiology, and end
results (SEER) program and pathology. Am J Surg Pathol.
40:e94–e102. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Healy MA, Morris AM, Abrahamse P, Ward KC,
Kato I and Veenstra CM: The accuracy of chemotherapy ascertainment
among colorectal cancer patients in the surveillance, epidemiology,
and end results registry program. BMC Cancer. 18:4812018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao J, Yuan P, Wang L, Wang Y, Ma H, Yuan
X, Lv W and Hu J: Clinical nomogram for predicting survival of
esophageal cancer patients after esophagectomy. Sci Rep.
6:266842016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun W, Jiang YZ, Liu YR, Ma D and Shao ZM:
Nomograms to estimate long-term overall survival and breast
cancer-specific survival of patients with luminal breast cancer.
Oncotarget. 7:20496–20506. 2016.PubMed/NCBI
|
|
12
|
Abu-Rustum NR, Zhou Q, Gomez JD, Alektiar
KM, Hensley ML, Soslow RA, Levine DA, Chi DS, Barakat RR and
Iasonos A: A nomogram for predicting overall survival of women with
endometrial cancer following primary therapy: Toward improving
individualized cancer care. Gynecol Oncol. 116:399–403. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iasonos A, Schrag D, Raj GV and Panageas
KS: How to build and interpret a nomogram for cancer prognosis. J
Clin Oncol. 26:1364–1370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weiser MR, Landmann RG, Kattan MW, Gonen
M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, et al:
Individualized prediction of colon cancer recurrence using a
nomogram. J Clin Oncol. 26:380–385. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ohori Tatsuo Gondo, Riu Hamada M, Gondo T
and Hamada R: Nomogram as predictive model in clinical practice.
Gan To Kagaku Ryoho. 6:901–906. 2009.(In Japanese).
|
|
16
|
Han DS, Suh YS, Kong SH, Lee HJ, Choi Y,
Aikou S, Sano T, Park BJ, Kim WH and Yang HK: Nomogram predicting
long-term survival after d2 gastrectomy for gastric cancer. J Clin
Oncol. 30:3834–3840. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Albert JM, Liu DD, Shen Y, Pan IW, Shih
YC, Hoffman KE, Buchholz TA, Giordano SH and Smith BD: Nomogram to
predict the benefit of radiation for older patients with breast
cancer treated with conservative surgery. J Clin Oncol.
30:2837–2843. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan
Z, Wan X, Liu G, Wu D, Shi L, et al: Prognostic nomogram for
intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin
Oncol. 31:1188–1195. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mariani P, Dureau S, Savignoni A, Rouic
LL, Levy-Gabriel C, Piperno-Neumann S, Rodrigues MJ, Desjardins L,
Cassoux N and Servois V: Development of a prognostic nomogram for
liver metastasis of uveal melanoma patients selected by liver MRI.
Cancers (Basel). 11(pii): E8632019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Woods JF, De Marchi JA, Lowery AJ and Hill
AD: Validation of a nomogram predicting sentinel lymph node status
in melanoma in an Irish population. Ir J Med Sci. 184:769–773.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang J, Pan Z, Zhao F, Feng X, Liu Q, Li Y
and Lyu J: A nomogram for predicting survival in patients with
nodular melanoma: A population-based study. Medicine (Baltimore).
98:e160592019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kavuluru R, Hands I, Durbin EB and Witt L:
Automatic extraction of ICD-O-3 primary sites from cancer pathology
reports. AMIA Jt Summits Transl Sci Proc 2013. 112–116. 2013.
|
|
23
|
Harrell FE Jr, Lee KL and Mark DB:
Multivariable prognostic models: Issues in developing models,
evaluating assumptions and adequacy, and measuring and reducing
errors. Stat Med. 15:361–387. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu Y, You S, Yang Z and Cheng S: Nomogram
predicting survival of hepatocellular carcinoma with portal vein
tumour thrombus after curative resection. ANZ J Surg. 89:E20–E25.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vickers AJ and Elkin EB: Decision curve
analysis: A novel method for evaluating prediction models. Med
Decis Making. 26:565–574. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rousson V and Zumbrunn T: Decision curve
analysis revisited: Overall net benefit, relationships to ROC curve
analysis, and application to case-control studies. BMC Med Inform
Decis Mak. 11:452011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mou K, Ding M, Han D, Zhou Y, Mu X, Liu W
and Wang L: miR-590-5p inhibits tumor growth in malignant melanoma
by suppressing YAP1 expression. Oncol Rep. 40:2056–2066.
2018.PubMed/NCBI
|
|
29
|
Shen W, Sakamoto N and Yang L:
Melanoma-specific mortality and competing mortality in patients
with non-metastatic malignant melanoma: A population-based
analysis. BMC Cancer. 16:4132016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu XL, Cheng H, Tang MS, Zhang HL, Wu RY,
Yu Y, Li X, Wang XM, Mai J, Yang CL, et al: A novel nomogram based
on LODDS to predict the prognosis of epithelial ovarian cancer.
Oncotarget. 8:8120–8130. 2017.PubMed/NCBI
|
|
31
|
Cai BB, Shi KQ, Li P, Chen BC, Shi L,
Johnson PJ, Lai P, Toyoda H and Zhou MT: A nomogram integrating
hepatic reserve and tumor characteristics for hepatocellular
carcinoma following curative liver resection. Clin Chim Acta.
485:187–194. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang W, Hong HJ and Chen YL:
Establishment of a gallbladder cancer-specific survival model to
predict prognosis in non-metastatic gallbladder cancer patients
after surgical resection. Dig Dis Sci. 63:2251–2258. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pietrantonio F, Barretta F, Fanotto V,
Park SH, Morano F, Fucà G, Niger M, Prisciandaro M, Silvestris N,
Bergamo F, et al: Estimating survival probabilities of advanced
gastric cancer patients in the second-line setting: The gastric
life nomogram. Oncology. 95:344–352. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ribero S, Stucci LS, Marra E, Marconcini
R, Spagnolo F, Orgiano L, Picasso V, Queirolo P, Palmieri G,
Quaglino P and Bataille V: Effect of age on melanoma risk,
prognosis and treatment response. Acta Derm Venereol. 98:624–629.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Reyes Ortiz CA, Freeman JL, Kuo YF and
Goodwin JS: The influence of marital status on stage at diagnosis
and survival of older persons with melanoma. J Gerontol A Biol Sci
Med Sci. 62:892–898. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang AJ, Rambhatla PV and Eide MJ: A
systematic review of socioeconomic and lifestyle factors and
melanoma. Br J Derm. 74:885–915. 2014.
|
|
37
|
McLaughlin JM, Fisher JL and Paskett ED:
Marital status and stage at diagnosis of cutaneous melanoma:
Results from the surveillance epidemiology and end results (SEER)
program, 1973–2006. Cancer. 117:1984–1993. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Arce PM, Camilon PR, Stokes WA, Nguyen SA
and Lentsch EJ: Is sex an independent prognostic factor in
cutaneous head and neck melanoma? Laryngoscope. 124:1363–1367.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vaithinathan AG and Asokan V: Public
health and precision medicine share a goal. J Evid Based Med.
10:76–80. 2017. View Article : Google Scholar : PubMed/NCBI
|
